Page last updated: 2024-10-24

celecoxib and Cancer of Duodenum

celecoxib has been researched along with Cancer of Duodenum in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
van Heumen, BW1
Roelofs, HM1
te Morsche, RH1
Nagengast, FM1
Peters, WH1
Phillips, RK1
Wallace, MH1
Lynch, PM1
Hawk, E1
Gordon, GB1
Saunders, BP1
Wakabayashi, N1
Shen, Y1
Zimmerman, S1
Godio, L1
Rodrigues-Bigas, M1
Su, LK1
Sherman, J1
Kelloff, G1
Levin, B1
Steinbach, G1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Prevention of Progression of Duodenal Adenomas to Cancer in Patients With Familial Adenomatous Polyposis (FAP)[NCT00808743]Phase 2/Phase 337 participants (Actual)Interventional2009-05-31Completed
Celecoxib for the Treatment of Non-muscle Invasive Bladder Cancer[NCT02343614]Phase 258 participants (Actual)Interventional2003-03-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for celecoxib and Cancer of Duodenum

ArticleYear
A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis.
    Gut, 2002, Volume: 50, Issue:6

    Topics: Adenomatous Polyposis Coli; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; C

2002

Other Studies

1 other study available for celecoxib and Cancer of Duodenum

ArticleYear
Duodenal mucosal risk markers in patients with familial adenomatous polyposis: effects of celecoxib/ursodeoxycholic acid co-treatment and comparison with patient controls.
    Orphanet journal of rare diseases, 2013, Nov-19, Volume: 8

    Topics: Adenomatous Polyposis Coli; Adult; Aged; Cadherins; Caspase 3; Celecoxib; Cyclooxygenase 2; Duodenal

2013